We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
Guidance for organisations when making decisions about the design and operation of enterprise IT services which handle OFFICIAL information.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Guidance on sexual transmission of Zika virus and methods of prevention.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
How to write up and share your findings
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Advice and guidance on the health needs of migrant patients from Solomon Islands for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Venezuela for healthcare practitioners.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
FCDO travel advice for Nepal. Includes safety and security, insurance, entry requirements and legal differences.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
FCDO travel advice for St Lucia. Includes safety and security, insurance, entry requirements and legal differences.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
Check the tariff classification for empty atomizers.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Things to consider when buying and using products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.